1. Bioactivity improvement via display of the hydrophobic core of HYD1 in a cyclic β‐hairpin‐like scaffold, MTI‐101. Issue 3 (9th October 2020) Authors: Jain, Priyesh; Badger, David B.; Liang, Yi; Gebhard, Anthony W.; Santiago, Daniel; Murray, Philip; Kaulagari, Sridhar R.; Gauthier, Ted J.; Nair, Rajesh; Kumar, MohanRaja; Guida, Wayne C.; Hazlehurst, Lori A.; McLaughlin, Mark L. Journal: Peptide science Issue: Volume 113:Issue 3(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High-content screen using zebrafish (Danio rerio) embryos identifies a novel kinase activator and inhibitor. Issue 9 (1st May 2017) Authors: Geldenhuys, Werner J.; Bergeron, Sadie A.; Mullins, Jackie E.; Aljammal, Rowaa; Gaasch, Briah L.; Chen, Wei-Chi; Yun, June; Hazlehurst, Lori A. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 27:Issue 9(2017) Page Start: 2029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Inhibition of the FAD containing ER oxidoreductin 1 (Ero1) protein by EN-460 as a strategy for treatment of multiple myeloma. Issue 8 (15th April 2019) Authors: Hayes, Karen E.; Batsomboon, Paratchata; Chen, Wei-Chih; Johnson, Brennan D.; Becker, Andreas; Eschrich, Steven; Yang, Yan; Robart, Aaron R.; Dudley, Gregory B.; Geldenhuys, Werner J.; Hazlehurst, Lori A. Journal: Bioorganic & medicinal chemistry Issue: Volume 27:Issue 8(2019) Page Start: 1479 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Targeting Intrinsic and Extrinsic Vulnerabilities for the Treatment of Multiple Myeloma. Issue 1 (21st June 2016) Authors: Anreddy, Nagaraju; Hazlehurst, Lori A. Journal: Journal of cellular biochemistry Issue: Volume 118:Issue 1(2017) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗